| |
|
Expiry Date or Comments |
| |
Structure and General |
|
| 1.1 |
Medicines Advisory Structure |
Under review |
| 1.2 |
Managed Introduction of New Medicines and Managed Introduction of New Oncology Medicines |
Dec 2023 |
| 1.3 |
Medicines Governance - Interim Processes during COVID-19 |
June 2025 |
| |
ADTC and Subcommittees |
|
| 2.1 |
Area Drug and Therapeutics Committee: Terms of Reference |
Oct 2026 |
| 2.2 |
Medicines Utilisation Subcommittee: Terms of Reference |
Under review |
| 2.3 |
Prescribing Interface Subcommittee: Terms of Reference |
March 2027 |
| 2.4 |
Non-Medicines Utilisation Subcommittee: Terms of Reference |
April 2025 |
| 2.4.1 |
Non-medical Prescribing Policy |
Under review |
| 2.4.2 |
Processes related to the Non-Medicines Formularies |
April 2027 |
| 2.4.3 |
Non-Medicines Utilisation Sub-Committee Guideline/ Formulary Checklist |
Sept 2021 |
| 2.5 |
Communications Subcommittee: Terms of Reference |
May 2027 |
| 2.6 |
Antimicrobial Utilisation Subcommittee: Terms of Reference |
Aug 2027 |
| 2.7 |
Safer Use of Medicines Subcommittee: Terms of Reference |
Nov 2025 |
| 2.8 |
Patient Group Direction Subcommittee: Terms of Reference |
Oct 2024 |
| |
Formulary Management |
|
| 3.1 |
Formulary Management Policy
You may also wish to refer to the Formulary process for non-prescription medicines and medical devices
|
Under review |
| |
Prescribing Management Group (PMG) and Subgroups |
|
| 4.1 |
Prescribing Management Group: Terms of Reference |
Feb 2020 |
| 4.2 |
Acute Services PMG: Terms of Reference |
Jan 2019 |
| 4.3 |
Primary Care PMG: Terms of Reference |
Jan 2022 |
| 4.4 |
PMG Finance Subgroup: Terms of Reference |
Feb 2020 |
| 4.5 |
PMG Mental Health: Terms of Reference |
Sept 2020 |
| |
Access to Medicines |
|
| 5.1 |
Non-Formulary Prescribing Policy |
August 2023 |
| 5.2 |
Peer Approved Clinical System (PACS Tier Two) Policy For related info and documentation, see HERE |
October 2023 |
| 5.3 |
Peer Approved Clinical Systems (PACS Ultra-Orphan) Policy
Please Note: The Scottish Government published guidance about a new Ultra-Orphan Pathway in April 2019. This guidance affects the applicability of the PACS UO process for many medicines. For further information, see the Non-Formulary page of this website (click here)
|
August 2023 |
| 5.4 |
Management of Individual Patient Treatment Requests (IPTRs) |
December 2025
|
| 5.5 |
Individual Patient Treatment Request (IPTR) Appeal process |
December 2025 |
| 5.6 |
Co-payment Policy for patients receiving aspects of care privately |
August 2025 |
| 5.7 |
Acute Unlicensed Medicines Policy (ULM Policy) |
Oct 2024 |
| 5.8 |
Medicines Access Scheme Policy (also see 5.8.1) |
Dec 2024 |
| 5.8.1 |
Medicines Access Scheme Interim Arrangements during COVID-19 |
Aug 2021 |
| 5.9 |
Ultra-Orphan Pathway |
New: In development |
| 5.10 |
Supply of Medicines Following Specialist Review or Clinic Appointments |
Dec 2023 |
| 5.10.1 |
Supply of Medicines Following Specialist Review - Additional Guidance for Mental Health |
Aug 2022 |
| |
Clinical and Handling of Medicines Policies |
|
| 6.1 |
Safe and Secure Handling of Medicines Policy and Guidance |
|
| 6.2 |
Administration of Intravenous (IV) Medicines and Flush Policy |
Sept 2026 |
| 6.3 |
Policy for Supply and Administration of Cytotoxic Intrathecal Systemic Anticancer Therapy |
Via StaffNet
Nov 2024
|
| 6.4 |
Policy for Non-Cytotoxic Intrathecal and Intraventricular Injections |
Under review |
| 6.4.1 |
Register of Authorised Non-Cytotoxic Intrathecal and Intracentricular Injections (Nov 2022) |
Nov 2025 |
| 6.5 |
Medicines Reconciliation in Hospital |
June 2023 |
| |
Clinical Guidelines |
|
| 7.1 |
Clinical Guidelines Framework |
Via Clinical Guidelines |
| 7.2 |
Development and Review Process and Clinical Guideline Title Page |
Via Clinical Guidelines |
| 7.3 |
Electronic Checklist for submission of Clinical Guidelines |
Via Clinical Guidelines |
| 7.4 |
AUC Antimicrobial Guideline Approval Process |
May 2021 |
| |
Miscellaneous |
|
| 8.1 |
Suspected Medicines Defect Policy |
Jan 2026 |
| 8.1.1 |
Suspected Medicines Defect Reporting Form (for use by acute pharmacy staff) |
Jan 2026 |
| 8.2 |
Symptomatic Relief Policy (Adults) |
April 2024 |
| 8.3 |
Medicines Alert and recall policy
NHSGGC chain of communications relating to medicines alerts
|
May 2027 |
| 8.4 |
PPSU Medicines Shortages Guidance via StaffNet |
2021 |
| 8.4.1 |
Patient Group Directions: Management of medicines shortages |
Jan 2026 |
